DPEP1 and colitis: Because GIV is required for the protective effects of MDP/NOD2 signaling in DSS-induced colitis (Figure 5, A–E), we next asked whether this protection arises from MDP’s ability to promote early induction of niCoIAMs, thereby accelerating recovery from acute colitis.